Table 7.
AmtRNA | |||
---|---|---|---|
IgG | IgM | ||
aCL | IgG | (–) 0.26 ± 0.43 | (–) 0.34 ± 0.40 |
(+) 0.42 ± 0.91 | (+) 0.56 ± 0.90 | ||
p = 0.14 | p = 0.01 | ||
IgM | (–) 0.26 ± 0.43 | (–) 0.33 ± 0.38 | |
(+) 0.53 ± 0.95 | (+) 0.86 ± 1.43 | ||
p = 0.19 | p = 0.002 | ||
Lupus anticoagulant | (–) 0.25 ± 0.45 | (–) 0.35 ± 0.40 | |
(+) 0.40 ± 0.67 | (+) 0.57 ± 0.98 | ||
p = 0.20 | p = 0.06 | ||
Anti-dsDNA antibodies | (–) 0.19 ± 0.28 | (–) 0.34 ± 0.41 | |
(+) 0.70 ± 0.71 | (+) 0.55 ± 0.27 | ||
p < 0.0001 | p = 0.10 |
Values presented as median ± IQR and Wilcoxon test p-value for patient positives (+) or negatives (–) for each variable.
aCL, anti-cardiolipin antibodies; AmtRNA, anti-mitochondrial RNA antibodies; Anti-dsDNA, antibodies against double-stranded DNA. Data in bold are statistically significant (p < 0.05).